National registry data on implantable cardioverter defibrillator treatment: What are they useful for?

Europace

Volumn 11, Issue 4, 2009, Pages 405-406

  Nielsen, Jens Cosedis ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVERSION; CLINICAL PRACTICE; COHORT ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; EDITORIAL; ELECTRIC BATTERY; HUMAN; IMPLANTATION; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ARRHYTHMIAS, CARDIAC; COST-BENEFIT ANALYSIS; DEFIBRILLATORS, IMPLANTABLE; GUIDELINE ADHERENCE; HEALTH PLANNING GUIDELINES; HUMANS; ITALY; REGISTRIES; RISK ASSESSMENT;

EID: 65249162784     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup007     Document Type: Editorial

References (6)

1. Proclemer A, Ghidina M, Gregori D, Facchin D, Rebellato L, Fioretti P et al. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. Europace 2009; advance access publication 9 January 2009;11:465- 475.
2. Mond HG, Irwin M, Ector H, Proclemer A. The world survey of cardiac pacing and cardioverter-defibrillators: calendar year 2005. PACE 2008;31:1202-12.
3. Møller M, Arnsbo P, Johansen JB. Danish pacemaker and ICD statistics 2007. 2008. www.pacemaker.dk
4. Tung R, Zimetbaum P, Josephson ME. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death. J Am Coll Cardiol 2008; 52:1111-21.
5. Biffi M, Ziacchi M, Bertini M, Sangiorgi D, Corsini D, Martignani C et al. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. Europace 2008;10:1288- 95.
6. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman D-B et al. Pacemaker and ICD generator malfunctions. Analysis of Food and Drug Administration annual reports. JAMA 2006;295:1901-6.